The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions
Abstract
Background There has been tremendous growth in research in pediatric multiple sclerosis (MS) and immune mediated central nervous system demyelinating disorders since operational definitions for these conditions were first proposed in 2007. Further, the International Pediatric Multiple Sclerosis Study Group (IPMSSG), which proposed the criteria, has expanded substantially in membership and in its international scope. Objective The purpose of this review is to revise the 2007 definitions in order to incorporate advances in delineating the clinical and neuroradiologic features of these disorders. Methods Through a consensus process, in which input was sought from the 150 members of the Study Group, criteria were drafted, revised and finalized. Final approval was sought through a web survey. Results Revised criteria are proposed for pediatric acute disseminated encephalomyelitis, pediatric clinically isolated syndrome, pediatric neuromyelitis optica and pediatric MS. These criteria were approved by 93% or more of the 56 Study Group members who responded to the final survey. Conclusions These definitions are proposed for clinical and research purposes. Their utility will depend on the outcomes of their application in prospective research.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although MS typically presents at age 20-50 years, approximately 0.5% of adults with MS have symptom onset at age 60 years or older. 42,43”
From Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria (2018) · cites this paper as [43]
In the citing paper
“In younger children (<12 years) MS may present differently from adolescents and adults; encephalopathy, multifocal neurological deficits (often with prominent brainstem/cerebellar involvement) and seizures are more common.32”
From Diagnosis of multiple sclerosis: progress and challenges (2017) · cites this paper as [32]
In the citing paper
“Up to 5% of people with MS develop their first symptoms in childhood, almost always RRMS. 32”
From Diagnosis of multiple sclerosis: progress and challenges (2017) · cites this paper as [32]
In the citing paper
“The performance of the McDonald 2010 criteria has been tested in children with CIS and the criteria have a similar sensitivity/specificity for the development of MS as in adult populations 35 but should not be applied in the setting of encephalopathy (i.e.ADEM).32”
From Diagnosis of multiple sclerosis: progress and challenges (2017) · cites this paper as [32]
In the citing paper
“ADEM is almost always monophasic; however, an encephalopathic ADEM-like illness can sometimes be the first presentation of MS in both children 32,34 and adults 43 and diagnostic criteria for ADEM remain imperfect.”
From Diagnosis of multiple sclerosis: progress and challenges (2017) · cites this paper as [32]
In the citing paper
“The clinical, imaging and laboratory features of ADEM and MS overlap and diagnostic criteria emphasise the requirement of encephalopathy (altered level of consciousness, behavioural or cognitive change) in making the diagnosis of ADEM (Supplementary Panel 1).32”
From Diagnosis of multiple sclerosis: progress and challenges (2017) · cites this paper as [32]
In the citing paper
“Older children (≥12 years) usually present with clinical features and MRI findings similar to adults with CIS.32,34”
From Diagnosis of multiple sclerosis: progress and challenges (2017) · cites this paper as [32]
Citations
Cites
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22366 · Cited by 9,802
Self-citationRevised diagnostic criteria for neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F., & Weinshenker, B. G. (2006) · Neurology · doi:10.1212/01.wnl.0000216139.44259.74 · Cited by 2,568
Barkhof, F. (1997) · Brain · doi:10.1093/brain/120.11.2059 · Cited by 1,251
Fisniku, L. K., Brex, P. A., Altmann, D. R., Miszkiel, K. A., Benton, C. E., Lanyon, R., Thompson, A. J., & Miller, D. H. (2008) · Brain · doi:10.1093/brain/awm329 · Cited by 897
Consensus definitions proposed for pediatric multiple sclerosis and related disorders
Krupp, L., Banwell, B., & Tenembaum, S. N. (2007) · Neurology · doi:10.1212/01.wnl.0000259422.44235.a8 · Cited by 757
Self-citationAcute disseminated encephalomyelitis
Tenembaum, S. N., Chamoles, N., & Fejerman, N. (2002) · Neurology · doi:10.1212/wnl.59.8.1224 · Cited by 708
Self-citationIncreased Relapse Rate in Pediatric-Onset Compared With Adult-Onset Multiple Sclerosis
Gorman, M., Healy, B. C., Polgar‐Turcsanyi, M., & Chitnis, T. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.505 · Cited by 459
Self-citationEarly onset multiple sclerosis
Бойко, А. Н., Vorobeychik, G., Paty, D. W., Devonshire, V., & Sadovnick, A. D. (2002) · Neurology · doi:10.1212/wnl.59.7.1006 · Cited by 417
Acute Disseminated Encephalomyelitis in Childhood: Epidemiologic, Clinical and Laboratory Features
Leake, J. A. D., Albani, S., Kao, A. S., Senac, M. O., Billman, G. F., Nespeca, M., Paulino, A., Quintela, E. R., Sawyer, M. H., & Bradley, J. S. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000133048.75452.dd · Cited by 411
Course and prognosis in early-onset MS
Simone, I. L., Carrara, D., Tortorella, C., Liguori, M., Lepore, V. L., Pellegrini, F., Bellacosa, A., Ceccarelli, A., Pavone, I., & Livrea, P. (2002) · Neurology · doi:10.1212/01.wnl.0000036907.37650.8e · Cited by 341
Cited by
Sorted by citations
Items 201–300 of 1,000
Beatty, C., Bowler, R. A., Farooq, O., Dudeck, L., Ramasamy, D. P., Yeh, E. A., Zivadinov, R., Weinstock‐Guttman, B., & Parrish, J. B. (2016) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2016.01.003 · Cited by 37
Serum neurofilament light chain in pediatric MS and other acquired demyelinating syndromes
Wong, Y. Y. M., Bruijstens, A. L., Barro, C., Michalak, Z., Melief, M., Wierenga‐Wolf, A. F., van Pelt, E. D., Neuteboom, R. F., Kühle, J., & Hintzen, R. Q. (2019) · Neurology · doi:10.1212/wnl.0000000000008057 · Cited by 37
Self-citationIn vivo gradients of thalamic damage in paediatric multiple sclerosis: a window into pathology
Meo, E. D., Storelli, L., Moiola, L., Ghezzi, A., Veggiotti, P., Filippi, M., & Rocca, M. A. (2020) · Brain · doi:10.1093/brain/awaa379 · Cited by 37
Self-citationBreastfeeding During Infancy Is Associated With a Lower Future Risk of Pediatric Multiple Sclerosis
Brenton, J. N., Engel, C. E., Sohn, M., & Goldman, M. D. (2017) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2017.09.007 · Cited by 36
Stefancin, P. L., Govindarajan, S. T., Krupp, L., Charvet, L. E., & Duong, T. Q. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.03.020 · Cited by 36
Self-citationWhat does first-line therapy mean for paediatric multiple sclerosis in the current era?
Hacohen, Y., Banwell, B., & Ciccarelli, O. (2020) · Multiple Sclerosis Journal · doi:10.1177/1352458520937644 · Cited by 37
Self-citationAlroughani, R., Huppke, P., Mazurkiewicz‐Bełdzińska, M., Blaschek, A., Vališ, M., Aaen, G. S., Pultz, J., Peng, X., & Beynon, V. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.606418 · Cited by 36
MOG and AQP4 Antibodies among Children with Multiple Sclerosis and Controls
Gaudioso, C., Mar, S., Casper, T. C., Codden, R. R., Nguyen, A., Aaen, G. S., Benson, L. A., Chitnis, T., Francisco, C., Gorman, M., et al. (2021) · Annals of Neurology · doi:10.1002/ana.26502 · Cited by 41
Self-citationPathophysiology, diagnosis, and management of neuroinflammation in covid-19
Brown, R. L., Benjamin, L. A., Lunn, M. P., Bharucha, T., Zandi, M. S., Hoskote, C., McNamara, P., & Manji, H. (2023) · BMJ · doi:10.1136/bmj-2022-073923 · Cited by 37
Long-term motor, cognitive and behavioral outcome of acute disseminated encephalomyelitis
Shilo, S., Michaeli, O., Shahar, E. M., & Ravid, S. (2016) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2016.01.008 · Cited by 35
Alroughani, R., Ahmed, S. F., Behbehani, R. S., & Al-Hashel, J. Y. (2017) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2017.01.017 · Cited by 35
Iro, M. A., Sadarangani, M., Goldacre, R., Nickless, A., Pollard, A. J., & Goldacre, M. J. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30114-7 · Cited by 35
Zhong, X., Zhou, Y., Chang, Y., Wang, J., Shu, Y., Sun, X., Peng, L., Lau, A. Y. L., Kermode, A. G., & Qiu, W. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00415 · Cited by 35
Sun, X., Qiu, W., Wang, J., Wang, S., Wang, Y., Zhong, X., Liu, C., Cui, C., Hong, H. Y., Yang, H., et al. (2020) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-322115 · Cited by 37
Post–COVID-19 Acute Disseminated Encephalomyelitis in a 17-Month-Old
McLendon, L. A., Rao, C. K., da Hora, C. C., Islamovic, F., & Galán, F. (2021) · PEDIATRICS · doi:10.1542/peds.2020-049678 · Cited by 35
Acute disseminated encephalomyelitis (ADEM) following COVID-19 vaccination: A systematic review
Nabizadeh, F., Noori, M., Rahmani, S., & Hosseini, H. (2023) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2023.03.008 · Cited by 34
The Spectrum of Inflammatory Acquired Demyelinating Syndromes in Children
Neuteboom, R. F., Wilbur, C., van Pelt, D., Rodriguez, M., & Yeh, E. A. (2017) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2017.08.007 · Cited by 37
Armangué, T., Capobianco, M. A. N., de Chalus, A., Giorgi, L., Deiva, K., Bruijstens, A. L., Wendel, E., Lechner, C., Bartels, F., Finke, C., et al. (2020) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2020.11.001 · Cited by 37
Self-citationStoian, A., Bajkó, Z., Stoian, M., Cioflinc, R. A., Niculescu, R., Arbănași, E. M., Russu, E., Botoncea, M., & Bălașa, R. (2023) · Vaccines · doi:10.3390/vaccines11071225 · Cited by 38
Li, K., Li, M., Wen, L., Wang, Q., Ding, X., & Wang, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.870867 · Cited by 40
Tantsis, E. M., Prelog, K., Alper, G. P., Benson, L. A., Gorman, M., Lim, M. J., Mohammad, S. S., Ramanathan, S., Brilot, F., Dale, R. C., et al. (2018) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.14114 · Cited by 33
Self-citationBody mass index trajectories in pediatric multiple sclerosis
Brenton, J. N., Woolbright, E., Abath, C. B., Qureshi, A., Conaway, M. R., & Goldman, M. D. (2019) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.14233 · Cited by 33
Libá, Z., Nohejlova, H., Čapek, V., Kršek, P., Šedivá, A., & Kayserová, J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219987 · Cited by 33
The spectrum of immune-mediated and inflammatory lesions of the brainstem
Law, L. Y., Riminton, S., Nguyen, M., Barnett, M. H., Reddel, S., & Hardy, T. A. (2019) · Neurology · doi:10.1212/wnl.0000000000008015 · Cited by 35
Diagnostic value of bright spotty lesions on MRI after a first episode of acute myelopathy
Rabasté, S., Cobo‐Calvo, Á., Nistiriuc-Muntean, V., Vukusic, S., Marignier, R., Cotton, F., Audoin, B., Ayrignac, X., Bourre, B., Ciron, J., et al. (2020) · Journal of Neuroradiology · doi:10.1016/j.neurad.2020.04.006 · Cited by 34
Nourbakhsh, B., Cordano, C., Asteggiano, C., Ruprecht, K., Otto, C., Rutatangwa, A., Lui, A., Hart, J., Flanagan, E. P., James, J. A., et al. (2021) · Annals of Neurology · doi:10.1002/ana.26062 · Cited by 33
Toussaint‐Duyster, L. C. C., Wong, Y. Y. M., Zijp, M. H. M. V. D. C., van Pelt, D., Catsman‐Berrevoets, C. E., Hintzen, R. Q., & Neuteboom, R. F. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517706038 · Cited by 32
Self-citationO'Mahony, J., Marrie, R., Laporte, A., Bar-Or, A., Yeh, E., Brown, A. D., Dilenge, M., & Banwell, B. (2018) · Multiple Sclerosis · doi:10.1177/1352458518796676 · Cited by 29
Self-citationEarly effective treatment may protect from cognitive decline in paediatric multiple sclerosis
Johnen, A., Elpers, C., Riepl, E., Landmeyer, N. C., Krämer, J., Polzer, P., Lohmann, H., Omran, H., Wiendl, H., Göbel, K., et al. (2019) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2019.08.007 · Cited by 32
Update on Pediatric Optic Neuritis
Gise, R. A., & Heidary, G. (2020) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-020-1024-x · Cited by 32
Early Predictors of 9‐Year Disability in Pediatric Multiple Sclerosis
Meo, E. D., Bonacchi, R., Moiola, L., Colombo, B., Sangalli, F., Zanetta, C., Amato, M. P., Martinelli, V., Rocca, M. A., & Filippi, M. (2021) · Annals of Neurology · doi:10.1002/ana.26052 · Cited by 34
Self-citationAcute Disseminated Encephalomyelitis
Filippi, M., & Rocca, M. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-38621-4_5 · Cited by 32
Machine learning classification of multiple sclerosis in children using optical coherence tomography
Ciftci-Kavaklioglu, B., Erdman, L., Goldenberg, A., Kavaklioğlu, C., Alexander, C., Oppermann, H. M., Patel, A., Hossain, S. Q., Berenbaum, T. S., Yau, O., et al. (2022) · Multiple Sclerosis Journal · doi:10.1177/13524585221112605 · Cited by 30
Self-citationRituximab treatment in pediatric‐onset multiple sclerosis
Breu, M., Sandesjö, F., Milos, R., Svoboda, J., Salzer, J., Schneider, L., Reichelt, J. B., Bertolini, A., Blaschek, A., Fink, K., et al. (2024) · European Journal of Neurology · doi:10.1111/ene.16228 · Cited by 31
Self-citationAdipokines are associated with pediatric multiple sclerosis risk and course
Keyhanian, K., Saxena, S., Gombolay, G. Y., Healy, B. C., Misra, M., & Chitnis, T. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.101384 · Cited by 31
Self-citationTherapy of Pediatric-Onset Multiple Sclerosis: State of the Art, Challenges, and Opportunities
Margoni, M., Rinaldi, F., Perini, P., & Gallo, P. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.676095 · Cited by 31
Acute disseminated encephalomyelitis and COVID-19: A systematic synthesis of worldwide cases
Zelada-Ríos, L., Pacheco‐Barrios, K., Galecio‐Castillo, M., Yamunaque-Chunga, C., Álvarez-Toledo, K. H., & Otiniano-Sifuentes, R. D. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577674 · Cited by 31
Shu, H., Ding, M., Shang, P., Song, J. T., Lang, Y., & Cui, L. (2022) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2021.782490 · Cited by 31
Gait Disturbance as the Presenting Symptom in Young Children With Anti-NMDA Receptor Encephalitis
Yeshokumar, A. K., Sun, L. R., Klein, J. L., Baranano, K. W., & Pardo, C. A. (2016) · PEDIATRICS · doi:10.1542/peds.2016-0901 · Cited by 32
Moccia, M., Palladino, R., Russo, C. V., Massarelli, M., Nardone, A., Triassi, M., Lugaresi, A., & Morra, V. B. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1078789 · Cited by 30
Tsuburaya, R. S., Miki, N., Tanaka, K., Kageyama, T., Irahara, K., Mukaida, S., Shiraishi, K., & Tanaka, M. (2014) · Brain and Development · doi:10.1016/j.braindev.2014.02.002 · Cited by 30
Chou, I., Wang, H.-S., Whitehouse, W. P., & Constantinescu, C. S. (2016) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-016-0663-4 · Cited by 30
Multiple Sclerosis in Pediatrics: Current Concepts and Treatment Options
Jančić, J., Nikolić, B., Ivančević, N., Djuric, V., Zaletel, I. V., Stevanović, D., Perić, S., van den Anker, J. N., & Samardžić, J. (2016) · Neurology and Therapy · doi:10.1007/s40120-016-0052-6 · Cited by 30
Differential diagnosis and evaluation in pediatric inflammatory demyelinating disorders
Rostasy, K. M., Bajer-Kornek, B., Venkateswaran, S., Hemingway, C. A., & Tardieu, M. (2016) · Neurology · doi:10.1212/wnl.0000000000002878 · Cited by 30
Self-citationFrequency and relevance of IgM, and IgA antibodies against MOG in MOG-IgG-associated disease
Pedreño, M., Sepúlveda, M., Armangué, T., Sabater, L., Martínez‐Hernández, E., Arrambide, G., Blanco, Y., Llufriú, S., Martínez‐Lapiscina, E. H., Mulero, P., et al. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.01.007 · Cited by 29
Santoro, J. D., & Chitnis, T. (2019) · Neuropediatrics · doi:10.1055/s-0039-1693152 · Cited by 29
Self-citationvon Wyl, V., Décard, B. F., Benkert, P., Lorscheider, J., Hänni, P., Lienert, C., Kühle, J., Derfuss, T. J., Kappos, L., & Yaldizli, Ö. (2020) · European Journal of Neurology · doi:10.1111/ene.14191 · Cited by 29
Evolution of diagnostic criteria for multiple sclerosis
Przybek-Skrzypecka, J., Gniatkowska, I., Mirowska-Guzel, D. M., & Członkowska, A. (2015) · Neurologia i Neurochirurgia Polska · doi:10.1016/j.pjnns.2015.07.006 · Cited by 32
Characteristics of pediatric multiple sclerosis: The Turkish pediatric multiple sclerosis database
Yılmaz, Ü., Anlar, B., Gücüyener, K., Yaramış, A., Cansu, A., Ünalp, A., Aksoy, A., Bayram, A. K., Kartal, A., Tosun, A. F., et al. (2017) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2017.06.004 · Cited by 29
Albassam, F., Longoni, G., Yea, C., Wilbur, C., Grover, S. A., & Yeh, E. A. (2019) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.14336 · Cited by 29
Newer Treatment Approaches in Pediatric-Onset Multiple Sclerosis
Macaron, G., Feng, J. J., Moodley, M., & Rensel, M. R. (2019) · Current Treatment Options in Neurology · doi:10.1007/s11940-019-0592-z · Cited by 29
Gklinos, P., & Dobson, R. (2024) · Antibodies · doi:10.3390/antib13020043 · Cited by 28
Neuroimaging of Infectious and Inflammatory Diseases of the Pediatric Cerebellum and Brainstem
Rossi, A., Martinetti, C., Morana, G., Severino, M., & Tortora, D. (2016) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2016.03.011 · Cited by 28
Charvet, L. E., Shaw, M., Frontario, A., Langdon, D. W., & Krupp, L. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517701588 · Cited by 28
Self-citationApplication of Plasma Exchange in Steroid-Responsive Encephalopathy
Jiang, Y., Tian, X., Gu, Y., Li, F., & Wang, X. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00324 · Cited by 28
Deiva, K., Huppke, P., Banwell, B. L., Chitnis, T., Gärtner, J., Krupp, L., Waubant, E., Stites, T., Pearce, G., & Merschhemke, M. (2019) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-321124 · Cited by 39
Self-citationLopes, C. C. B., Brucki, S. M. D., Neto, C. E. B. P., Corazza, L. A., Baima, J. P. S., Fiorentino, M. D., Tatsch, J. F. S., Martin, M. D. G. M., Lucato, L. T., Gomes, H. R., et al. (2020) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20200186 · Cited by 27
Behavioral Symptoms in Pediatric Multiple Sclerosis
Charvet, L. E., Cersosimo, B. H., Schwarz, C., Belman, A. L., & Krupp, L. (2016) · Journal of Child Neurology · doi:10.1177/0883073816636227 · Cited by 28
Self-citationLee, J., & Chitnis, T. (2016) · Seminars in Neurology · doi:10.1055/s-0036-1579738 · Cited by 28
Self-citationPediatric Multiple Sclerosis: Genes, Environment, and a Comprehensive Therapeutic Approach
Cappa, R. N., Theroux, L. M., & Brenton, J. N. (2017) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2017.07.005 · Cited by 29
Boesen, M. S., Magyari, M., Born, A. P., & Thygesen, L. C. (2018) · Clinical Epidemiology · doi:10.2147/clep.s156997 · Cited by 28
Hofer, L., Mariotto, S., Wurth, S., Ferrari, S., Mancinelli, C. R., Delogu, R., Monaco, S., Gajofatto, A., Schwaiger, C., Rostasy, K. M., et al. (2019) · Multiple Sclerosis Journal - Experimental Translational and Clinical · doi:10.1177/2055217319848463 · Cited by 29
Self-citationMultiple sclerosis in children
Banwell, B. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52001-2.00018-2 · Cited by 28
Self-citationDiagnose der Multiplen Sklerose: Revision der McDonald-Kriterien 2017
Aktaş, O., Wattjes, M. P., Stangel, M., & Hartung, H. (2018) · Der Nervenarzt · doi:10.1007/s00115-018-0550-0 · Cited by 52
Boesen, M. S., Blinkenberg, M., Thygesen, L. C., Eriksson, F., & Magyari, M. (2020) · Multiple Sclerosis Journal · doi:10.1177/1352458520959673 · Cited by 28
Zhang, M., Shen, J., Zhou, S., Du, X., Li, W., Yu, L., Zhang, Y., Wang, Y., & Zhang, L. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.593287 · Cited by 27
Tumefactive demyelination: updated perspectives on diagnosis and management
Sánchez, P., Chan, F., & Hardy, T. A. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1971077 · Cited by 27
LaRovere, K. L., Poussaint, T. Y., Young, C. C., Newhams, M. M., Kücükak, S., Irby, K., Kong, M. Y. F., Schwartz, S. P., Walker, T. C., Bembea, M. M., et al. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2022.3881 · Cited by 27
Shukla, N. M., Casper, T. C., Ness, J., Wheeler, Y., Chitnis, T., Lotze, T. E., Gorman, M., Benson, L. A., Weinstock‐Guttmann, B., Aaen, G. S., et al. (2023) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2023.04.020 · Cited by 27
Self-citationSex differences and subclinical retinal injury in pediatric-onset MS
Graves, J., Chohan, H., Cedars, B. E., Arnow, S., Yiu, H., Waubant, E. L., & Green, A. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516652497 · Cited by 27
Pediatric-Onset Multiple Sclerosis: A Single Center Study
Yamamoto, E. A., Ginsberg, M. R., Rensel, M. R., & Moodley, M. (2017) · Journal of Child Neurology · doi:10.1177/0883073817739789 · Cited by 27
Conti, F., Moratti, M., Leonardi, L., Catelli, A., Bortolamedi, E., Filice, E., Fetta, A., Fabi, M., Facchini, E., Cantarini, M. E., et al. (2023) · Cells · doi:10.3390/cells12192417 · Cited by 26
T cell cytokine signatures: Biomarkers in pediatric multiple sclerosis
Cala, C. M., Moseley, C. E., Steele, C. H., Dowdy, S. M., Cutter, G., Ness, J., & DeSilva, T. M. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.04.015 · Cited by 27
Encefalitis autoinmunes: criterios diagnósticos y pautas terapéuticas
Collao-Parra, J. P., Romero-Urra, C., & Delgado, C. (2018) · Revista médica de Chile · doi:10.4067/s0034-98872018000300351 · Cited by 26
Autoimmune and Paraneoplastic Myelopathies
Zalewski, N. L., & Flanagan, E. P. (2018) · Seminars in Neurology · doi:10.1055/s-0038-1660856 · Cited by 26
Validated age-specific reference values for CSF total protein levels in children
Kahlmann, V., Roodbol, J., van Leeuwen, N., Ramakers, C. R. B., van Pelt, D., Neuteboom, R. F., Catsman‐Berrevoets, C. E., de Wit, M. Y., & Jacobs, B. C. (2017) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2017.03.006 · Cited by 25
Differential Binding of Autoantibodies to MOG Isoforms in Inflammatory Demyelinating Diseases
Schanda, K., Peschl, P., Lerch, M., Seebacher, B., Mindorf, S., Ritter, N., Probst, M., Hegen, H., Pauli, F. D., Wendel, E., et al. (2021) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000001027 · Cited by 27
Self-citationUpdate on pathology of central nervous system inflammatory demyelinating diseases
Kalinowska, A., Guo, Y., & Lucchinetti, C. F. (2022) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.a2022.0046 · Cited by 29
Fukushima, N., SUZUKI, M. T., Ogawa, R., Hayashi, K., Takanashi, J., & Ohashi, T. (2017) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.cn-001078 · Cited by 25
Acute Disseminated Encephalomyelitis
Gray, M. P., & Gorelick, M. H. (2016) · Pediatric Emergency Care · doi:10.1097/pec.0000000000000825 · Cited by 25
Impaired growth of the cerebellum in pediatric-onset acquired CNS demyelinating disease
Weier, K., Fonov, V., Aubert-Broche, B., Arnold, D. L., Banwell, B., & Collins, D. L. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515615224 · Cited by 25
Self-citationPediatric MOG-Ab–Associated Encephalitis
Kim, N. N., Champsas, D., Eyre, M., Abdel‐Mannan, O., Lee, V. W. M., Skippen, A., Chitre, M., Forsyth, R. J., Hemingway, C. A., Kneen, R., et al. (2024) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200323 · Cited by 24
Self-citationMOG antibody seropositivity in a patient with encephalitis: beyond the classical syndrome
Mariotto, S., Monaco, S., Peschl, P., Coledan, I., Mazzi, R., Höftberger, R., Reindl, M., & Ferrari, S. (2017) · BMC Neurology · doi:10.1186/s12883-017-0971-6 · Cited by 24
Khera, D., Didel, S., Panda, S., Tiwari, S., & Singh, K. (2021) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003124 · Cited by 24
Nagireddy, R. B. R., Kumar, A., Singh, V. K., Prasad, R., Pathak, A., Chaurasia, R. N., Mishra, V. N., & Joshi, D. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577742 · Cited by 24
Kornbluh, A. B., & Kahn, I. L. (2023) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2023.101054 · Cited by 26
Nationwide Incidence of Acquired Central Nervous System Demyelination in Icelandic Children
Gudbjornsson, B. T., Haraldsson, Á., Einarsdóttir, H., & Thorarensen, Ó. (2015) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2015.08.020 · Cited by 24
Gray matter–related proteins are associated with childhood-onset multiple sclerosis
Singh, V. P., van Pelt, E. D., Stoop, M. P., Stingl, C., Ketelslegers, I. A., Neuteboom, R. F., Catsman‐Berrevoets, C. E., Luider, T. M., & Hintzen, R. Q. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000155 · Cited by 25
Self-citationEvolution of MRI abnormalities in paediatric acute disseminated encephalomyelitis
Wong, Y. Y. M., van Pelt, E. D., Ketelslegers, I. A., Catsman‐Berrevoets, C. E., Hintzen, R. Q., & Neuteboom, R. F. (2016) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2016.08.014 · Cited by 24
Self-citationAn update on multiple sclerosis in children: diagnosis, therapies, and prospects for the future
Gordon‐Lipkin, E. M., & Banwell, B. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1360135 · Cited by 25
Self-citationDiffusion tensor magnetic resonance imaging in very early onset pediatric multiple sclerosis
Rocca, M. A., Sonkin, M., Copetti, M., Pagani, E., Arnold, D. L., Narayanan, S., Sled, J. G., Banwell, B., & Filippi, M. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515596600 · Cited by 25
Self-citationClinical Characteristics of Pediatric-Onset and Adult-Onset Multiple Sclerosis in Hispanic Americans
Langille, M. M., Islam, T. S., Burnett, M., & Amezcua, L. (2016) · Journal of Child Neurology · doi:10.1177/0883073816638754 · Cited by 23
Ismail, F., Gordon‐Lipkin, E. M., Huether, K., Blair, I., Szólics, M., Alsaadi, T. M., Aziz, F., Suleiman, J., & Schiess, N. (2018) · Journal of Child Neurology · doi:10.1177/0883073818759103 · Cited by 23
Florea, A., Maurey, H., Sauter, M. L., Bellesme, C., Sevin, C., & Deiva, K. (2019) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.14242 · Cited by 23
Spinal Cord Involvement in MS and Other Demyelinating Diseases
Marrodán, M., Gaitán, M. I., & Correale, J. D. (2020) · Biomedicines · doi:10.3390/biomedicines8050130 · Cited by 23
Micheletti, L., Maldonado, F., Watal, P., Toronchik, M. S., Erripa, J. I., Princich, J. P., & Rugilo, C. (2021) · Pediatric Radiology · doi:10.1007/s00247-021-05188-4 · Cited by 23
The State of the Art of Pediatric Multiple Sclerosis
Teleanu, R. I., Niculescu, A.-G., Vladâcenco, O. A., Roza, E., Perjoc, R., & Teleanu, D. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098251 · Cited by 28
Saponaro, A.-C., Tully, T., Maillart, É., Maurey, H., & Deiva, K. (2023) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2023.05.001 · Cited by 23
International Pediatric MS Study Group Global Members Symposium report
Wassmer, E., Chitnis, T., Pohl, D., Amato, M. P., Banwell, B., Ghezzi, A., Hintzen, R. Q., Krupp, L., Makhani, N., Rostasy, K. M., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002880 · Cited by 23
Self-citationMagnetic resonance imaging diagnosis of demyelinating diseases: An update
Miki, Y. (2019) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12501 · Cited by 22
Metadata
- Authors
- Krupp, L. B., Tardieu, M., Amato, M. P., Banwell, B., Chitnis, T., Dale, R. C., Ghezzi, A., Hintzen, R., Kornberg, A., Pohl, D., Rostasy, K., Tenembaum, S., Wassmer, E., & for the International Pediatric Multiple Sclerosis Study Group
- Affiliations
- Stony Brook University Hospital (US)
- Hôpitaux universitaires Paris Sud (FR)
- University of Florence (IT)
- Children's Hospital of Philadelphia (US)
- Massachusetts General Hospital (US)
- The University of Sydney (AU)
- Centro Studi Sclerosi Multipl, Ospedale di Gallarate, Italy
- Erasmus MC (NL)
- Royal Children's Hospital (AU)
- Children's Hospital of Eastern Ontario (CA)
- Innsbruck Medical University (AT)
- Garrahan Hospital (AR)
- Birmingham Children's Hospital (GB)
- Corresponding author
- Krupp, Lauren B
- Tardieu, Marc
- ORCID
- Venue
- Multiple Sclerosis Journal
- Publisher
- SAGE Publications
- Published
- 2013-04-09
- Volume
- 19
- Issue
- 10
- Pages
- 1261-1267
- ISSN
- 1352-4585 (ISSN-L)
- 1477-0970
- OpenAlex
- W2025358672
- Cited by
- 1,130
- References
- 37
- Citations by year
- 2026: 57 · 2025: 74 · 2024: 95 · 2023: 111 · 2022: 102 · 2021: 106 · 2020: 99 · 2019: 100 · 2018: 98 · 2017: 93 · 2016: 80 · 2015: 60 · 2014: 42 · 2013: 10
- FWCI
- 47.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Multiple Sclerosis Journal (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Florence Research (University of Florence) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Oncology › Polyomavirus and related diseases
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Keywords
- pediatric multiple sclerosis, diagnostic criteria, acute disseminated encephalomyelitis, neuromyelitis optica, clinical features, consensus definition
- MeSH terms
- Child, Encephalomyelitis, Acute Disseminated, Humans, Multiple Sclerosis, Neuromyelitis Optica, Pediatrics, Demyelinating Autoimmune Diseases, CNS
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
